Observational studyThe Lancet. Infectious diseases2024

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.

Oleksandr Korotych et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.